Regulations have a substantial impact on public health in the United States and elsewhere, affecting our exposure to environmental, transportation, food, tobacco, terrorism, and other risks. They are also an area where the use of decision analytic tools (especially benefit-cost analysis) has been required for many years. CHDS Senior Research Scientist Lisa A. Robinson explains the new requirements for regulatory analysis under the Trump Administration and the challenges facing analysts working in this arena. Her essay is part of a series entitled “New Developments in Regulatory Benefit-Cost Analysis.”
Learn more: Access the article.
Related news: Hammitt and Robinson Work on Benefit-Cost Analysis Guidelines
Related news: CHDS Faculty Chair Panels at National Meeting